Xuzhen Yan
No. 95 Yong'an Road, Xicheng District
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Activation of aryl hydrocarbon receptor alleviates cholestatic liver injury by inhibiting inflammation.
Journal: Cell communication and signaling : CCS
Published: August 19, 2025
ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: August 05, 2025
ITGA8 deficiency in hepatic stellate cells attenuates CCl4-Induced liver fibrosis via suppression of COL11A1.
Journal: Biochemical and biophysical research communications
Published: February 14, 2025
Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis.
Journal: Cellular and molecular gastroenterology and hepatology
Published: January 24, 2025
Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation.
Journal: Theranostics
Published: January 02, 2025
Role of branched chain amino acid metabolism on aging.
Journal: Biogerontology
Published: December 28, 2024
Mitochondria-Associated Membranes in Aging and Senescence.
Journal: Aging and disease
Published: June 01, 2024
Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal.
Journal: Hepatology communications
Published: October 31, 2023
Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and Mdr2-/--induced cholestatic liver fibrosis.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 24, 2023
Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
Journal: Biochemical and biophysical research communications
Published: October 03, 2023
Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling.
Journal: JHEP reports : innovation in hepatology
Published: June 25, 2023
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities.
Journal: Hepatology (Baltimore, Md.)
Published: October 27, 2022
Last Updated: 09/26/2026